AG: Pharmaceutical Company Settles Allegations of Off Label Marketing of Botox

Attorney General J.B. Van Hollen announced today that Wisconsin joined the federal government and other states to reach an agreement with pharmaceutical manufacturer, Allergan, Inc., and Allergan USA, Inc., to settle allegations of improper off-label marketing of the drug Botox.  The agreement was reached in principle last fall, and today Wisconsin Medicaid received settlement proceeds in the amount of $563,456.12, as the state share of the $1,273,937.50 attributable to Wisconsin Medicaid, the remainder of which goes to the federal government.

Read the full release.